(Q42169660)
Statements
1 reference
Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes (English)
1 reference
Orville G Kolterman
1 reference
Mark S Fineman
1 reference
Eling Gaines
1 reference
Sonja Heintz
1 reference
Thomas A Bicsak
1 reference
Kristin Taylor
1 reference
Dennis Kim
1 reference
Maria Aisporna
1 reference
Yan Wang
1 reference
Alain D Baron
1 reference
1 July 2003
1 reference
1 reference
Identifiers
1 reference